Researchers have identified new variations in neuroblastoma that could lead to a more accurate prognosis and better-targeted treatments for this devastating childhood cancer.
Neuroblastoma study identifies new subgroups with distinct prognoses and potential vulnerabilities to therapies retrieved 9 April 2024 from https://medicalxpress.com/news/2024-04-neuroblastoma-subgroups-distinct-prognoses-potential.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.22 hours ago Use this form if you have come across a typo, inaccuracy or would like to send an edit request for the content on this page. For general inquiries, please use ourThank you for taking time to provide your feedback to the editors.
Your feedback is important to us. However, we do not guarantee individual replies due to the high volume of messages.to let the recipient know who sent the email. Neither your address nor the recipient's address will be used for any other purpose. The information you enter will appear in your e-mail message and is not retained by Medical Xpress in any form.Get weekly and/or daily updates delivered to your inbox.
Medicine Research Health Research News Health Research Health Science Medicine Science
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Researchers discover a signaling molecule in neuroblastoma immunosuppression and aggressivenessThe MYCN oncoprotein (proteins related to the growth of cancer cells) plays a key role in starting, advancing and making it difficult to treat various human cancers.
Read more »
BU study reveals key to combating high-risk neuroblastomaThe MYCN oncoprotein (proteins related to the growth of cancer cells) plays a key role in starting, advancing and making it difficult to treat various human cancers.
Read more »
Study successfully mimics complex neuroblastoma vasculature on a chip to explore treatmentsNeuroblastoma, one of the most common childhood cancers, is classified as a developmental cancer because it arises prenatally during the formation of organs and tissues. It originates from cancer cells that develop in neuroblasts, a type of immature nerve tissue, and primarily affects the adrenal glands.
Read more »
Exploring olive oil compounds oleuropein and hydroxytyrosol as potential treatments for neuroblastomaThe therapeutic potential of oleuropein (OLE) and hydroxytyrosol (HT) from olive oil.
Read more »
Researchers Awarded $3.2 Million Grant to Study Treatment Resistance in Cutaneous MelanomaA team of investigators from UCLA Health and UAMS Winthrop P. Rockefeller Cancer Institute received a $3.2 million grant to study treatment resistance in cutaneous melanoma. The researchers aim to identify new ways to prevent and overcome resistance to targeted therapy in all sub-types of this aggressive form of skin cancer.
Read more »
Researchers study newborn piglets to better understand the progression of influenzaAlthough prevention and treatment strategies are available for influenza, they are not sufficient for vulnerable populations such as young children and newborns.
Read more »